Back to Journals
Journal of Pain Research
Research and Network Development, Boston PainCare, United States
Editor-in-Chief: Dr. Michael E Schatman Ph.D., CPE
Dr. Schatman is a clinical psychologist who has spent the past 30 years working in multidisciplinary chronic pain management. He currently serves on the teaching faculty at Tufts School of Medicine’s Department of Public Health & Community Medicine in Boston, MA, and the Research Division of Boston Pain Care.
Dr. Schatman is the author of over 100 journal articles and book chapters on various aspects of chronic pain management, and lectures regularly on pain management on local, national and international bases. He is also the editor of Ethical Issues in Chronic Pain Management and Chronic Pain Management: Guidelines for Multidisciplinary Program Development, both of which were released by Informa Healthcare in 2007. Dr. Schatman is on the editorial review boards of the Journal of Pain, Pain Medicine, Pain Practice, Pain & Therapy, the World Journal of Anesthesiology and Psychological Injury & Law, serving as the Ethics Forum co-Editor of Pain Medicine and as the Ethics co-Section Head of Psychological Injury & Law. He is the Secretary of the Western Pain Society, resurrected and served as the Chairperson of the Ethics Special Interest Group of the American Pain Society from 2008-2013, is a member of the Ethics Committee of the American Pain Society, the Ethics Council of the American Academy of Pain Medicine, and is on the Board of Directors of the American Society of Pain Educators – which named him 2011 Clinical Pain Educator of the Year.
Pharmaceutical and Administrative Sciences, Presbyterian College School of Pharmacy, United States
Associate Editor: Katherine Hanlon
Dr. Katherine Hanlon is a Rita Allen Foundation scholar and the Director of Research at Presbyterian College with a faculty appointment in the School of Pharmacy. Dr. Hanlon received a B.S. in Biochemistry and Molecular Biophysics followed by a Ph.D. in Pharmacology at the University of Arizona. The Hanlon lab explores macrophage differentiation and function in biological systems with a particular focus on the functional implications of neuro-immune communication between neuronal cell bodies and tissue resident macrophages in the dorsal root ganglia as it pertains to nociception. Proinflammatory mediators released by peripheral immune cells contribute to the sensitization of nociceptors in response to injury, suggesting that modification of immune cell activity may alter plasticity and ultimately the perception of persistent pain. The Hanlon lab is working to target macrophages in to develop novel non-opioid targets for the treatment of pain.
A distinct but equally important point of focus in the Hanlon laboratory relates to modulation of tumor associated macrophage function in breast cancer. These are novel and timely investigations contributing to a growing body of research indicating that the need for toxic chemotherapeutic regimens may be lessened with the addition of immunomodulating compounds. To date, tumor associated macrophages (TAMs) have been incompletely studied as a potential immunomodulatory target to improve disease outcome, despite the demonstrated contribution of TAMs to tumor development. The Hanlon lab investigates novel pathways in the modulation of TAMs with the goal of developing novel therapeutics for the treatment of breast cancer and other solid tumors.
Pain Mechanisms Laboratory, Wake Forest University, United States
Associate Editor: E. Alfonso Romero-Sandoval
Dr. Romero-Sandoval studies the molecular mechanisms of cannabinoid receptor activation in skin and immune cells in the induction of analgesia, resolution of inflammation, and promotion of tissue repair. The Romero-Sandoval laboratory explores the role of endocannabinoids in postoperative pain and its transition to persistent postoperative pain in addition to the function of phosphatases and kinases in spinal cord and the peripheral nervous system. Most recently Dr. Romero-Sandoval has focused on elucidating the role of macrophages in wound healing and the transition from acute to chronic pain in the context of diabetic neuropathy or surgical pain. The ultimate goal of the Romero-Sandoval lab is to restore the molecular mechanisms and cellular functions that are altered under pathological inflammatory and painful conditions. The Romero-Sandoval laboratory uses highly translatable clinical approaches such as the use of human primary cells, the use of clinically relevant functional assays, and the use of clinically tested nanotechnology for potential cell-directed gene therapies.
Dr. Romero-Sandoval has held academic positions as Instructor (2007-2009) and Assistant Professor (2009-2012) at Geisel Dartmouth Medical School, Associate Professor and the Director of Research at Presbyterian College School of Pharmacy in Clinton, SC. Currently (April 2017-present) he is an Associate Professor of Anesthesiology in the Pain Mechanisms Laboratory at Wake Forest University School of Medicine, Winston Salem, NC.
IFNAP, Institute of Neurological Sciences, Germany
Associate Editor: Michael A. Ueberall
Dr. Ueberall is associate professor for pediatrics and pediatric neurology at the University Erlangen, Germany. He is a board certified pain specialists, works as medical director of the private Institute of Neurological Sciences, Algesiology and Pediatrics (IFNAP) and chairs the Center of Excellence for Health Care Research of the German Pain Association in Nuernberg, Germany. Dr. Ueberall is president of the German Pain League (Europe’s largest umbrella organization for patients suffering from chronic pain) since 2012 and Vice-President of the German Pain Association (Europe’s largest organization of pain practitioners) since 2003.
Clinical Pharmacy, Stratton VA Medical Center, United States
Associate Editor: Erica Wegrzyn
Dr. Erica Wegrzyn graduated from Western New England University College of Pharmacy. She completed a PGY-1 general practice residency at MaineGeneral Medical Center, Augusta, Maine and PGY-2 specialty residency in pain and palliative care at the Stratton VA Medical Center, Albany, New York. Currently she is an advanced practice clinical pharmacy specialist in pain management at the Stratton VA Medical Center specializing in chronic noncancer pain and palliative care. She is adjunct faculty at both Western New England University College of Pharmacy and Albany College of Pharmacy & Health Sciences. Her research interests include buprenorphine and other unique opioids as an alternative to traditional opioids, opioid transition and dosing, in-home naloxone distribution, emergency response, and technology platforms to promote opioid safety. She has numerous publications related to pharmacotherapeutics and pain. She holds consultant positions with Remitigate LLC and NovaPain Associates. Dr. Wegrzyn has taken emergency response to another level, as she is also a NYS volunteer firefighter.
Phillip J. Albrecht, Vice-President, Integrated Tissue Dynamics, Rensselaer, NY, USA
Yoichi Aota, MD. Vice President. Yokohama Brain & Spine Center, Japan
Amina Barkat, Professor, Chief of Medicine & Neonatal Resuscitation, National Reference Centre of Neonatology & Nutrition, Children's Hospital of Rabat, University Mohammed V Souissi Rabat, Rabat, Morocco
Abdulbari Bener, Advisor to WHO, Professor of Public Health, Dept. of Biostatistics & Medical Informatics, Cerrahpaşa Faculty of Medicine, Istanbul University, Turkey
Robert Caudle, Professor, Department of Oral, Maxillofacial Surgery and Diagnostic Sciences, University of Florida College of Dentistry, FL, USA
Rupert Conrad, Head of Research, Department of Psychosomatic Medicine and Psychotherapy, Bonn University Hospital, Germany
Benoit Foligné, Faculté des Sciences Biologiques et Pharmaceutiques de Lille and Lille Inflammation Research International Center, Université Lille 2, France
Robert J Gatchel, Professor, Department of Psychology, College of Science, University of Texas at Arlington, TX, USA
Michael S. Gold, PhD, Department of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
Dr. Thomas B. Gregory, Clinical Pharmacy Specialist- Pain Management, Department of Pharmacy, CoxHealth Medical Center, Springfield, MO, USA.
Mitchell Haas, Adjunct Associate Professor, Integrative Health & Wellbeing Program, Earl E. Bakken Center for Spirituality and Healing, University of Minnesota, Minneapolis, MN, USA
Tommaso Iannitti, PhD, FHEA, Charles River Discovery Research Services Ltd., Somerset, UK.
Mithilesh K. Jha, Ph.D., Post-Doctoral Research Fellow, Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Prof. Dr. Kasai
Yuichi Kasai, Professor, Department of Spinal Surgery and Medical Engineering, Mie University Graduate School of Medicine, Mie, Japan
Professor Keppel Hesselink
Jan M Keppel Hesselink, Professor Molecular Pharmacology, Faculty of Health, University of Witten/Herdecke, Witten, Germany; Institute for Neuropathic Pain, Bosch en Duin, The Netherlands
Igor Kissin, Professor of Anaesthesia, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
Dr La Rosa
Valentina Lucia La Rosa Psy.D., Psychotherapist, Unit of Psychodiagnostics and Clinical Psychology, University of Catania, Catania, Italy.
Halina Machelska, Professor, Klinik für Anaesthesiologie und operative Intensivmedizin, Charité-Universitätsmedizin, Berlin, Germany
Paul Martin, Director, Research School of Psychology, The Australian National University, ACT; Adjunct Professor, School of Applied Psychology and Menzies Health Institute Queensland, Griffith University; Adjunct Professor, Department of Psychiatry, Southern Clinical School, Monash University, Australia
Diana S Meske, Senior Manager, Clinical Development & Scientific Affairs, Collegium Pharmaceutical, Boston, MA, USA.
Laurent Misery, Professor, Head of Department of Dermatology, University Hospital of Brest, Brest, France; Director of the Laboratory of Neurosciences, University of Western Brittany, Brest, France
Anne Z. Murphy, Ph.D., Professor, Neuroscience Institute, Georgia State University, Atlanta, GA USA
Sri Nalamachu, MD, Founder and Medical Director, Mid America Polyclinic, Overland Park KS; Clinical Associate Professor, Kansas City University of Medicine and Biosciences, Kansas City, MO, USA
Abraham Ochoa-Aguilar, Professor of Human Physiology and Board Member of The Research Department, La Salle Faculty of Medicine; CEO of HLL private research center, Mexico City, Mexico
Lintao Qu, M.D., Ph.D., Assistant Professor of Neurosurgery, Neurosurgery Pain Research Institute, Johns Hopkins University School of Medicine.
Yolanda Rios, Professor, Centro de Investigaciones Químicas, Universidad Autónoma del Estado de Morelos, MS, México
Richard Robinson, Division of Psychology, Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Rainer Sabatowski, Professor, Comprehensive Pain Center, Technical University Dresden, Medical Faculty, Dresden, Germany
Prof. Dr. Santarcangelo
Department of Translational Research and New Technologies in Medicine and Surgery, Pisa University, Italy.
Richard J. Traub, Ph.D., Professor and Vice Chair, Department of Neural and Pain Sciences, School of Dentistry; Program in Neuroscience; UM Center to Advance Chronic Pain Research; University of Maryland, Baltimore, MD, USA
Jeffrey Mitchell Weinberg, Associate Clinical Professor of Dermatology, Mount Sinai School of Medicine, New York, NY, USA
Ting Xia, Assistant Professor, Department of Mechanical Engineering, College of Engineering & Engineering Technology, Northern Illinois University, Illinois, USA
Prof. Dr. Xing
Guogang Xing, Department of Neurobiology, Neuroscience Research Institute, Peking University
Xiaoshu Zhu, Associate Professor, School of Science and Health, University of Western Sydney, NSW, Australia